Market Place
Sourcing Support
All News #Library
Others
Septerna to Participate in Upcoming Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Novo strikes $2.2B deal with Septerna to new obesity treatments
14 May 2025 //
REUTERS
Septerna Reports Q4 and Full Year 2024 Financial Results
27 Mar 2025 //
GLOBENEWSWIRE
Septerna Appoints Gil Labrucherie As Chief Financial Officer
06 Jan 2025 //
GLOBENEWSWIRE
Septerna goes public with upsized offering of $288M
26 Oct 2024 //
FIERCE BIOTECH
Goldman-backed drug developer Septerna raises $288 mln in US IPO
24 Oct 2024 //
REUTERS
Septerna`s GPCR Platform Therapeutic Potential At ENDO 2024
03 Jun 2024 //
BUSINESSWIRE
Septerna to Present Preclinical Data from GPCR Drug Discovery Engine at ENDO 24
20 May 2024 //
BUSINESSWIRE
Septerna Appoints Bernard Coulie and Shalini Sharp to its Board of Directors
06 Feb 2024 //
BUSINESSWIRE
Septerna Announces Novel GPCR-targeted Program Acquired by Vertex
12 Sep 2023 //
BUSINESSWIRE
Vertex gets in on GPCR game, paying Septerna $47M for program
12 Sep 2023 //
FIERCE BIOTECH
Septerna Bolsters Leadership Team as Company Advances its Multi-Product Pipeline
31 Aug 2023 //
BUSINESSWIRE
Septerna snags $150M series B for next-gen GPCR drugs
11 Jul 2023 //
FIERCE BIOTECH
Septerna Secures $150 Million in Series B Financing
11 Jul 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.